Adam Pascale - Hemispherx Biopharma Chief Accounting Officer
Executive
Mr. Adam Pascale CPA, is no longer Chief Financial Officer of the Company, effective September 15, 2019. He was named Chief Financial Officer in February 2016, in addition to his current responsibilities as Chief Accounting Officer. Mr. Pascale was employed with Hemispherx since 1996, with more than two decades of public accounting experience and prior public company experience. He earned a Bachelor of Arts degree in Accounting and Finance from Rutgers University since 2016.
| Age | 67 |
| Tenure | 8 years |
| Professional Marks | CPA |
| Phone | 215-988-0080 |
| Web | http://www.hemispherx.net |
Hemispherx Biopharma Management Efficiency
The company has Return on Asset of (50.05) % which means that on every $100 spent on assets, it lost $50.05. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (128.89) %, meaning that it generated no profit with money invested by stockholders. Hemispherx Biopharma's management efficiency ratios could be used to measure how well Hemispherx Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.The company has 4.89 M in debt with debt to equity (D/E) ratio of 74.6, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Hemispherx Biopharma has a current ratio of 2.11, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Hemispherx Biopharma until it has trouble settling it off, either with new capital or with free cash flow. So, Hemispherx Biopharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hemispherx Biopharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hemispherx to invest in growth at high rates of return. When we think about Hemispherx Biopharma's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Carol Helliker | CenterPoint Energy | 63 | |
| Bertha Villatoro | CenterPoint Energy | N/A | |
| Marian Walt | Harmony Gold Mining | 44 | |
| Janine Pelosi | Zoom Video Communications | 41 | |
| Henrika Basterfield | Harmony Gold Mining | N/A | |
| Steven Woodward | Antero Midstream Partners | 65 | |
| Riana Bisschoff | Harmony Gold Mining | 40 | |
| Simon Gardiner | United Utilities Group | 55 | |
| Tony Gardner | CenterPoint Energy | N/A | |
| Jacqueline Richert | CenterPoint Energy | 40 | |
| Abre Vuuren | Harmony Gold Mining | 57 | |
| Lauren Fourie | Harmony Gold Mining | N/A | |
| Matthew Saxon | Zoom Video Communications | N/A | |
| Melanie NaidooVermaak | Harmony Gold Mining | 43 | |
| Nick Chong | Zoom Video Communications | N/A | |
| Steve Greenley | CenterPoint Energy | N/A | |
| Sheri Pearce | Antero Midstream Partners | 56 | |
| Jon McEvers | Antero Midstream Partners | N/A | |
| Darin Carroll | CenterPoint Energy | N/A | |
| Darren Jameson | United Utilities Group | N/A | |
| Vincent Mercaldi | CenterPoint Energy | N/A | |
Management Performance
| Return On Equity | -128.89 | |||
| Return On Asset | -50.05 |
Hemispherx Biopharma Leadership Team
Elected by the shareholders, the Hemispherx Biopharma's board of directors comprises two types of representatives: Hemispherx Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hemispherx. The board's role is to monitor Hemispherx Biopharma's management team and ensure that shareholders' interests are well served. Hemispherx Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hemispherx Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wayne Springate, Sr. VP of Operations and Chairman of Disclosure Controls Committee | ||
| Adam Pascale, Chief Accounting Officer | ||
| Ann Coverly, Director of Admin. and HR and Investor Relations Manager | ||
| Stewart Appelrouth, Director | ||
| David Strayer, Chief Medical Officer, Medical Director - Regulatory Affairs | ||
| William Carter, Chairman of the Board, CEO, Chief Scientific Officer | ||
| William Mitchell, Independent Director | ||
| Peter Rodino, Director | ||
| Thomas Equels, Executive Vice Chairman of the Board, CFO, General Counsel, Secretary, Litigation Counsel | ||
| Charles Jones, Associates Public Relations | ||
| Iraj Kiani, Lead Independent Director |
Hemispherx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hemispherx Biopharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -128.89 | |||
| Return On Asset | -50.05 | |||
| Current Valuation | 7.7 M | |||
| Shares Outstanding | 251.49 K | |||
| Shares Owned By Insiders | 12.78 % | |||
| Shares Owned By Institutions | 6.09 % | |||
| Number Of Shares Shorted | 133.15 K | |||
| Price To Earning | (0.86) X | |||
| Price To Book | 0.80 X | |||
| Price To Sales | 15.35 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hemispherx Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hemispherx Biopharma's short interest history, or implied volatility extrapolated from Hemispherx Biopharma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Hemispherx Biopharma information on this page should be used as a complementary analysis to other Hemispherx Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Hemispherx Stock
If you are still planning to invest in Hemispherx Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemispherx Biopharma's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |